Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report.

作者
Edward M. Gilbert,D G Renlund,J B O'Connell,Clement Eiswirth,G Rothstein,W A Gay,M R Bristow
出处
期刊:PubMed [National Institutes of Health]
卷期号:6 (6): 369-74 被引量:6
链接
标识
摘要

Because vincristine has immunosuppressive activity in animal models, has specific cytotoxic effects on lymphocytes, and does not have overlapping toxicity with other immunosuppressive agents, we designed a prospective randomized trial to evaluate the efficacy of the addition of vincristine to standard immunosuppressive therapy in heart transplantation. Patients received equine antithymocyte globulin for the first week or murine antihuman mature T cell (OKT3) monoclonal antibody for the first 2 weeks after transplantation and were maintained on azathioprine and cyclosporine. A steroid pulse was administered 1 day after completion of antithymocyte globulin or OKT3 monoclonal antibody and tapered off over 21 days. Vincristine was given at 0.025 mg/kg intravenously for eight dosages over 12 weeks, beginning 2 days after completion of antithymocyte globulin or OKT3 monoclonal antibody. Fifty-two patients were randomized (26 were given vincristine, and 26 were not). The addition of vincristine to the regimen of patients receiving antithymocyte globulin resulted in significantly fewer episodes of rejection at 1 month (vincristine, 0.2 +/- 0.1; no vincristine, 1.2 +/- 0.2; p less than 0.001), at 3 months (vincristine, 1.2 +/- 0.1; no vincristine, 2.5 +/- 0.3; p less than 0.001), and at 6 months (vincristine, 1.9 +/- 0.2; no vincristine, 2.9 +/- 0.3; p less than 0.001). It also resulted in significantly more patients being successfully weaned off daily steroids (vincristine, 67%; no vincristine, 20%; p = 0.04). The addition of vincristine to the regimen of patients receiving early rejection prophylaxis with OKT3 monoclonal antibody did not alter rejection incidence or steroid usage.(ABSTRACT TRUNCATED AT 250 WORDS)

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
粒粒粒粒发布了新的文献求助10
刚刚
1秒前
执着的盼雁完成签到,获得积分10
1秒前
活泼宛海完成签到 ,获得积分10
1秒前
北酱完成签到,获得积分10
1秒前
1秒前
张博发布了新的文献求助50
1秒前
QDU的应助被mmy采纳,获得10
2秒前
牛马研究生完成签到,获得积分10
2秒前
www发布了新的文献求助10
2秒前
热心市民小红花的应助被闫妍采纳,获得10
2秒前
3秒前
3秒前
昭明发布了新的文献求助10
3秒前
丘比特的应助被ff采纳,获得10
3秒前
Crush发布了新的文献求助10
3秒前
研友_VZG7GZ的应助被vivien采纳,获得10
3秒前
Maud完成签到 ,获得积分10
4秒前
完美世界的应助被茉莉三分甜采纳,获得10
4秒前
4秒前
自觉谷蓝发布了新的文献求助10
5秒前
Rea完成签到,获得积分10
5秒前
岁末完成签到 ,获得积分20
6秒前
jeff发布了新的文献求助10
6秒前
吉吉完成签到 ,获得积分10
6秒前
甜甜发布了新的文献求助10
6秒前
完美访烟完成签到,获得积分10
6秒前
7秒前
秋风的应助被张博采纳,获得10
7秒前
7秒前
7秒前
遇见完成签到,获得积分10
7秒前
大意的忆寒完成签到,获得积分10
7秒前
7秒前
04d的应助被gaoyiqing采纳,获得10
8秒前
妍宝贝完成签到 ,获得积分10
8秒前
端庄南莲完成签到,获得积分10
8秒前
现代的雯完成签到,获得积分10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185